Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
UTMD

Market Cap: $221.96M

UI

Utah Medical Products, Inc.

UTMD

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin54.88%

EBITDA Margin40.62%

EBIT Margin33.94%

Pre-tax Margin35.68%

Net Profit Margin29.04%

Earnings Yield4.73%

Valuation Multiples

Price / Book1.82

Price / Sales6.15

Price / Earnings21.25

PEG-1.73

Forward PEG-1.73

EV / Sales6.15

EV / EBITDA15.15

EV / Operating Cash Flow18.75

EV / Free Cash Flow19.41

Price / Free Cash Flow19.39

Price / Operating Cash Flow18.73

Cash Flow & Capital

Free Cash Flow / Share$3.6

Operating Cash Flow / Share$3.72

Free Cash Flow Yield5.16%

Capex / Revenue1.11%

Capex / Operating Cash Flow3.38%

Capex / Depreciation0.24

Stock Compensation / Revenue1.10%

Dividend Payout Ratio37.58%

Dividend Yield1.77%

Liquidity & Leverage

Current Ratio48.62

Quick Ratio44.27

Cash Ratio0.00

Debt / Assets0.00

Debt / Capital0.00

Debt / Equity0.00

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA0.01

Solvency Ratio5.08

Financial Leverage1.02

Efficiency & Working Capital

Asset Turnover0.29

Fixed Asset Turnover3.75

Inventory Turnover1.81

Receivables Turnover10.13

Payables Turnover18.60

Days Sales Outstanding36.04

Days Inventory Outstanding201.7

Days Payables Outstanding19.63

Operating Cycle237.74

Cash Conversion Cycle218.11

Working Capital Turnover0.37

Returns & Quality

Return on Equity8.74%

Return on Assets8.42%

Return on Invested Capital6.83%

ROCE8.39%

Return on Tangible Assets9.51%

Operating Return on Assets8.25%

Income Quality1.13

Tax Burden0.81

Interest Burden1.05

Balance Sheet & Intrinsic Metrics

Enterprise Value$222.15M

Invested Capital$122.5M

Working Capital$98.57M

Tangible Asset Value$107.73M

Net Current Asset Value$98.1M

Graham Number$53.3

Graham Net-Net$28.95

Book Value / Share$38.33

Tangible Book Value / Share$33.84

Cash / Share$27.49

Financial Health Scores

Piotroski Score7

Altman Z-Score55.50

Revenue$36.11M

EBIT$12.25M

Market Cap$221.96M

Working Capital$98.57M

Retained Earnings$131.95M

Total Assets$124.57M

Total Liabilities$2.54M